MCL coexpression mm9:907: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0000467!1.23e-13!308;UBERON:0000480!1.23e-13!308;UBERON:0005423!2.61e-12!304;UBERON:0007023!2.08e-10!51;UBERON:0000923!2.50e-10!291;UBERON:0010316!2.50e-10!291;UBERON:0005291!2.50e-10!291;UBERON:0006598!2.50e-10!291;UBERON:0010317!2.50e-10!291;UBERON:0002532!2.50e-10!291;UBERON:0002050!2.55e-10!294;UBERON:0000477!1.12e-08!244 | |ontology_enrichment_uberon=UBERON:0000467!1.23e-13!308;UBERON:0000480!1.23e-13!308;UBERON:0005423!2.61e-12!304;UBERON:0007023!2.08e-10!51;UBERON:0000923!2.50e-10!291;UBERON:0010316!2.50e-10!291;UBERON:0005291!2.50e-10!291;UBERON:0006598!2.50e-10!291;UBERON:0010317!2.50e-10!291;UBERON:0002532!2.50e-10!291;UBERON:0002050!2.55e-10!294;UBERON:0000477!1.12e-08!244 | ||
|tfbs_overrepresentation_for_novel_motifs=0.393008,0.121181,0.367606,0.434198,0.720982,0.448401,0.538088,0.515265,0.535519,0.0447303,0.494602,0.526159,0.173454,0.550255,0.756943,0,0.742571,0.703873,0.483643,0.0887261,0.332107,0.0622758,0.549359,0.258745,0.374936,0.577606,0.466037,0.469052,0.303071,0.376624,0.455168,0.843667,0.699026,0.425071,0.276324,0.185086,0.242032,0.522578,0.631914,0.195877,0.712303,0.460258,0.204736,0.27776,0.209497,0.423266,0.662995,0.484612,0.386968,0.305876,0.725127,0.604356,0.362495,0.985264,1.00271,0.557354,0.314394,0.513517,0.447041,0.555328,0.823643,0.613749,0.192045,0.713876,0.568415,0.754324,1.139,1.48833,0.818971,1.34113,0.349355,0.527912,0.0665967,1.03623,0.140213,0.409836,0.42492,0.651651,0.806481,0.336166,0.530481,0.759925,1.48701,0.167672,0.920903,0.025519,0.0299392,0.757533,0.667883,1.65055,1.20871,0.925879,0.856465,0.265734,0.218233,1.10739,0.982739,0.859272,0.663249,0.101559,1.26039,0.843387,0.967837,0.725721,0.724668,0.459825,0.784351,0.480639,0.340849,0.333829,1.00333,0.96962,0.337254,1.24884,1.21576,0.708441,0.143112,0.437894,0.743872,0.238599,1.04163,0.692953,0.579418,0.650748,1.26989,0.810177,0.546178,0.849691,1.13749,0.268537,0.950857,1.09252,1.10792,0.570914,1.23736,0.061199,0.401212,0.461647,1.18819,2.01886,1.6187,1.14372,0.591394,0.854131,0.718197,0.460705,0.666107,1.9792,0.403515,0.261837,0.120154,0.0553085,0.986833,0.207643,0.569994,1.06851,0.605358,0.287226,0.39061,0.400939,1.1977,0.920047,0.810622,0.383936,0.714896,0.562634,0.240994,0.524587,0.166768 | |||
}} | }} |
Revision as of 19:06, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:60043268..60043282,- | p@chr11:60043268..60043282 - |
Mm9::chr11:98216623..98216634,+ | p@chr11:98216623..98216634 + |
Mm9::chr11:98218352..98218393,+ | p@chr11:98218352..98218393 + |
Mm9::chr12:101444635..101444669,+ | p@chr12:101444635..101444669 + |
Mm9::chr14:22652104..22652140,+ | p3@Vdac2 |
Mm9::chr3:101396429..101396470,- | p@chr3:101396429..101396470 - |
Mm9::chr4:154932366..154932388,+ | p@chr4:154932366..154932388 + |
Mm9::chr6:17616260..17616279,+ | p@chr6:17616260..17616279 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0003869 | 4-nitrophenylphosphatase activity | 0.0121607183681279 |
GO:0031944 | negative regulation of glucocorticoid metabolic process | 0.0121607183681279 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 0.0121607183681279 |
GO:0048521 | negative regulation of behavior | 0.0121607183681279 |
GO:0045989 | positive regulation of striated muscle contraction | 0.0121607183681279 |
GO:0007621 | negative regulation of female receptivity | 0.0121607183681279 |
GO:0005890 | sodium:potassium-exchanging ATPase complex | 0.0121607183681279 |
GO:0007603 | phototransduction, visible light | 0.0121607183681279 |
GO:0050795 | regulation of behavior | 0.0121607183681279 |
GO:0060181 | female receptivity | 0.0121607183681279 |
GO:0045924 | regulation of female receptivity | 0.0121607183681279 |
GO:0031946 | regulation of glucocorticoid biosynthetic process | 0.0121607183681279 |
GO:0006942 | regulation of striated muscle contraction | 0.0121607183681279 |
GO:0060180 | female mating behavior | 0.0121607183681279 |
GO:0030641 | cellular hydrogen ion homeostasis | 0.0159587566872052 |
GO:0031943 | regulation of glucocorticoid metabolic process | 0.0159587566872052 |
GO:0004865 | type 1 serine/threonine specific protein phosphatase inhibitor activity | 0.0170180109904335 |
GO:0007213 | acetylcholine receptor signaling, muscarinic pathway | 0.0170180109904335 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 0.0170180109904335 |
GO:0043388 | positive regulation of DNA binding | 0.0170180109904335 |
GO:0045933 | positive regulation of muscle contraction | 0.0170180109904335 |
GO:0006704 | glucocorticoid biosynthetic process | 0.0170180109904335 |
GO:0045823 | positive regulation of heart contraction | 0.0170180109904335 |
GO:0008599 | protein phosphatase type 1 regulator activity | 0.0170180109904335 |
GO:0008308 | voltage-gated ion-selective channel activity | 0.0170180109904335 |
GO:0045822 | negative regulation of heart contraction | 0.0180444616373082 |
GO:0022892 | substrate-specific transporter activity | 0.0180444616373082 |
GO:0051099 | positive regulation of binding | 0.0180444616373082 |
GO:0019218 | regulation of steroid metabolic process | 0.0180444616373082 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 0.0180444616373082 |
GO:0015991 | ATP hydrolysis coupled proton transport | 0.0180444616373082 |
GO:0033057 | reproductive behavior in a multicellular organism | 0.0180444616373082 |
GO:0055067 | monovalent inorganic cation homeostasis | 0.0180444616373082 |
GO:0015988 | energy coupled proton transport, against electrochemical gradient | 0.0200129639191323 |
GO:0007617 | mating behavior | 0.021260861824116 |
GO:0008211 | glucocorticoid metabolic process | 0.021260861824116 |
GO:0005391 | sodium:potassium-exchanging ATPase activity | 0.0223767893786798 |
GO:0051101 | regulation of DNA binding | 0.0223767893786798 |
GO:0005795 | Golgi stack | 0.0239800433466738 |
GO:0002026 | regulation of the force of heart contraction | 0.0269502260834755 |
GO:0007618 | mating | 0.0269502260834755 |
GO:0019098 | reproductive behavior | 0.0283284086761825 |
GO:0004864 | protein phosphatase inhibitor activity | 0.0316137486258903 |
GO:0019212 | phosphatase inhibitor activity | 0.0350785630125739 |
GO:0019216 | regulation of lipid metabolic process | 0.0350785630125739 |
GO:0005741 | mitochondrial outer membrane | 0.0350785630125739 |
GO:0051098 | regulation of binding | 0.0361342198503228 |
GO:0030317 | sperm motility | 0.0366201476483536 |
GO:0031968 | organelle outer membrane | 0.0366201476483536 |
GO:0051705 | behavioral interaction between organisms | 0.0366201476483536 |
GO:0007602 | phototransduction | 0.0366201476483536 |
GO:0009584 | detection of visible light | 0.0377195160290655 |
GO:0050962 | detection of light stimulus during sensory perception | 0.0377195160290655 |
GO:0050908 | detection of light stimulus during visual perception | 0.0377195160290655 |
GO:0017111 | nucleoside-triphosphatase activity | 0.0393926317897043 |
GO:0009583 | detection of light stimulus | 0.0393926317897043 |
GO:0042383 | sarcolemma | 0.0396695758421618 |
GO:0016462 | pyrophosphatase activity | 0.0396695758421618 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 0.0396695758421618 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 0.0396695758421618 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0396695758421618 |
GO:0006941 | striated muscle contraction | 0.0396695758421618 |
GO:0042493 | response to drug | 0.0397496267172885 |
GO:0007200 | G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | 0.0397496267172885 |
GO:0019888 | protein phosphatase regulator activity | 0.0417358677902161 |
GO:0006937 | regulation of muscle contraction | 0.0417496164970557 |
GO:0005834 | heterotrimeric G-protein complex | 0.0417496164970557 |
GO:0019208 | phosphatase regulator activity | 0.0435752009425995 |
GO:0042446 | hormone biosynthetic process | 0.0435752009425995 |
GO:0008016 | regulation of heart contraction | 0.0435752009425995 |
GO:0048193 | Golgi vesicle transport | 0.0453357959224003 |
GO:0008217 | regulation of blood pressure | 0.0470462002640027 |
GO:0048015 | phosphoinositide-mediated signaling | 0.048363880397671 |
GO:0003015 | heart process | 0.048363880397671 |
GO:0050909 | sensory perception of taste | 0.048363880397671 |
GO:0009582 | detection of abiotic stimulus | 0.048363880397671 |
GO:0060047 | heart contraction | 0.048363880397671 |
GO:0019867 | outer membrane | 0.0499003376276443 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
anatomical system | 1.23e-13 | 308 |
anatomical group | 1.23e-13 | 308 |
developing anatomical structure | 2.61e-12 | 304 |
adult organism | 2.08e-10 | 51 |
germ layer | 2.50e-10 | 291 |
germ layer / neural crest | 2.50e-10 | 291 |
embryonic tissue | 2.50e-10 | 291 |
presumptive structure | 2.50e-10 | 291 |
germ layer / neural crest derived structure | 2.50e-10 | 291 |
epiblast (generic) | 2.50e-10 | 291 |
embryonic structure | 2.55e-10 | 294 |
anatomical cluster | 1.12e-08 | 244 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |